PAX4
PAX4 is a member of the paired box (PAX) family of transcription factors. Members of this gene family typically contain a paired box domain, an octapeptide, and a paired-type homeodomain. These genes play critical roles during fetal development and cancer growth. The paired box 4 gene is involved in pancreatic islet development and mouse studies have demonstrated a role for this gene in differentiation of insulin-producing beta cells.
                Full Name
                    Paired Box 4
                Function
                    Plays an important role in the differentiation and development of pancreatic islet beta cells. Transcriptional repressor that binds to a common element in the glucagon, insulin and somatostatin promoters. Competes with PAX6 for this same promoter binding site. Isoform 2 appears to be a dominant negative form antagonizing PAX4 transcriptional activity.
                Biological Process
                    Anatomical structure developmentManual Assertion Based On ExperimentIBA:GO_Central
Animal organ morphogenesisManual Assertion Based On ExperimentTAS:ProtInc
Cell differentiationIEA:UniProtKB-KW
Pancreas developmentIEA:InterPro
Regulation of transcription by RNA polymerase IIManual Assertion Based On ExperimentIBA:GO_Central
                Animal organ morphogenesisManual Assertion Based On ExperimentTAS:ProtInc
Cell differentiationIEA:UniProtKB-KW
Pancreas developmentIEA:InterPro
Regulation of transcription by RNA polymerase IIManual Assertion Based On ExperimentIBA:GO_Central
Cellular Location
                    Nucleus
                Involvement in disease
                    Diabetes mellitus, non-insulin-dependent (NIDDM):
A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.
Diabetes mellitus, insulin-dependent (IDDM):
A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.
Diabetes mellitus, ketosis-prone (KPD):
An atypical form of diabetes mellitus characterized by an acute initial presentation with severe hyperglycemia and ketosis, as seen in classic type 1 diabetes, but after initiation of insulin therapy, prolonged remission is often possible with cessation of insulin therapy and maintenance of appropriate metabolic control. Metabolic studies show a markedly blunted insulin secretory response to glucose, partially reversible with the improvement of blood glucose control. Variable levels of insulin resistance are observed, especially in obese patients. Pancreatic beta-cell autoimmunity is a rare finding.
Maturity-onset diabetes of the young 9 (MODY9):
A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.
                A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.
Diabetes mellitus, insulin-dependent (IDDM):
A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.
Diabetes mellitus, ketosis-prone (KPD):
An atypical form of diabetes mellitus characterized by an acute initial presentation with severe hyperglycemia and ketosis, as seen in classic type 1 diabetes, but after initiation of insulin therapy, prolonged remission is often possible with cessation of insulin therapy and maintenance of appropriate metabolic control. Metabolic studies show a markedly blunted insulin secretory response to glucose, partially reversible with the improvement of blood glucose control. Variable levels of insulin resistance are observed, especially in obese patients. Pancreatic beta-cell autoimmunity is a rare finding.
Maturity-onset diabetes of the young 9 (MODY9):
A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.
                            View more
                        
   
                    Anti-PAX4 antibodies
 + Filters
		 Loading...
Loading...
        Target: PAX4
                
                Host: Mouse
                
                Antibody Isotype: IgG
                
                Specificity: Human
                
                Clone: CBT991
                
                Application*: WB, E
                
            Target: PAX4
                
                Host: Mouse
                
                Antibody Isotype: IgG1
                
                Specificity: Human
                
                Clone: CBT3746
                
                Application*: WB
                
            Target: PAX4
                
                Host: Mouse
                
                Antibody Isotype: IgG2a
                
                Specificity: Human
                
                Clone: CBYC-P183
                
                Application*: WB, E
                
            Target: PAX4
                
                Host: Mouse
                
                Antibody Isotype: IgG2b
                
                Specificity: Human
                
                Clone: 3H1
                
                Application*: WB
                
            Target: PAX4
                
                Host: Mouse
                
                Antibody Isotype: IgG1
                
                Specificity: Human
                
                Clone: 3C12
                
                Application*: E, WB, P, IF, IC, F
                
            Target: PAX4
                
                Host: Mouse
                
                Antibody Isotype: IgG2a
                
                Specificity: Human
                
                Clone: 2F3
                
                Application*: WB
                
            More Infomation
Hot products 
    - 
            Mouse Anti-APP Recombinant Antibody (DE2B4) (CBMAB-1122-CN)  
- 
            Mouse Anti-ADV Recombinant Antibody (V2-503423) (CBMAB-V208-1364-FY)  
- 
            Mouse Anti-BIRC5 Recombinant Antibody (6E4) (CBMAB-CP2646-LY)  
- 
            Mouse Anti-CD33 Recombinant Antibody (6C5/2) (CBMAB-C8126-LY)  
- 
            Mouse Anti-CRTAM Recombinant Antibody (CBFYC-2235) (CBMAB-C2305-FY)  
- 
            Mouse Anti-ACTN4 Recombinant Antibody (V2-6075) (CBMAB-0020CQ)  
- 
            Mouse Anti-ADGRL2 Recombinant Antibody (V2-58519) (CBMAB-L0166-YJ)  
- 
            Human Anti-SARS-CoV-2 Spike Recombinant Antibody (CBC05) (CBMAB-CR005LY)  
- 
            Mouse Anti-ADIPOR1 Recombinant Antibody (V2-179982) (CBMAB-A1368-YC)  
- 
            Mouse Anti-CD24 Recombinant Antibody (2Q1282) (CBMAB-C1624-CN)  
- 
            Mouse Anti-CCNH Recombinant Antibody (CBFYC-1054) (CBMAB-C1111-FY)  
- 
            Rabbit Anti-AKT3 Recombinant Antibody (V2-12567) (CBMAB-1057-CN)  
- 
            Mouse Anti-BRCA2 Recombinant Antibody (CBYY-0790) (CBMAB-0793-YY)  
- 
            Mouse Anti-ASH1L Monoclonal Antibody (ASH5H03) (CBMAB-1372-YC)  
- 
            Mouse Anti-AAV-5 Recombinant Antibody (V2-503417) (CBMAB-V208-1369-FY)  
- 
            Mouse Anti-AMOT Recombinant Antibody (CBYC-A564) (CBMAB-A2552-YC)  
- 
            Mouse Anti-ATG5 Recombinant Antibody (9H197) (CBMAB-A3945-YC)  
- 
            Mouse Anti-BSN Recombinant Antibody (219E1) (CBMAB-1228-CN)  
- 
            Mouse Anti-CAPZB Recombinant Antibody (CBYY-C0944) (CBMAB-C2381-YY)  
- 
            Rat Anti-CCR2 Recombinant Antibody (475301) (CBMAB-C1338-LY)  
For Research Use Only. Not For Clinical Use.
                    (P): Predicted
* Abbreviations 
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
 
                Online Inquiry
                
    
           
        
 Compare
Compare 
        


